Oral treatment with uracil-tegafur, etoposide and leucovorin in non-Asian patients with recurrent non-small cell lung cancer: A non-randomized, phase II study

被引：0
|
作者：
Surmont, V. F.
Aerts, J.
Pouw, E.
Vernhout, R. M.
Gras, E. J.
Tan, K. Y.
Hoogsteden, H.
van Klaveren, R.
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Groene Hartziekenhuis, Gouda, Netherlands
[4] St Franciscus Gasthuis, Rotterdam, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19019
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of oral topotecan in advanced non-small cell lung cancer
    White, SC
    Cheeseman, S
    Thatcher, N
    Anderson, H
    Carrington, B
    Hearn, S
    Ross, G
    Ranson, M
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 868 - 873
  • [22] Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
    Isla, Dolores
    De Las Penas, Ramon
    Insa, Amelia
    Marse, Raquel
    Martinez-Banaclocha, Natividad
    Mut, Pilar
    Moran, Teresa
    Angeles Sala, Maria
    Massuti, Bartomeu
    Laura Ortega, Ana
    Miguel Jurado, Jose
    Gomez-Codina, Jose
    Diz, Pilar
    Artal, Angel
    Gutierrez, Vanesa
    Francisca Vazquez, Maria
    Vinolas, Nuria
    Maestu, Inmaculada
    Camps, Carlos
    Alvarez, Rosa
    de Mon Soto, Melchor Alvarez
    Ponce, Santiago
    Provencio, Mariano
    LUNG CANCER, 2019, 135 : 161 - 168
  • [23] Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study
    Francois, Eric
    Smith, Denis
    Dahan, Laetitia
    Michel, Cecile
    Perrier, Herve
    Mari, Veronique
    Seitz, Jean-Francois
    Follana, Philippe
    Evesque, Ludovic
    Chamorey, Emmanuel
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (04) : 207 - 211
  • [24] Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer
    Zucchetti, M
    Pagani, O
    Torri, V
    Sessa, C
    DIncalci, M
    DeFusco, M
    deJong, J
    Gentili, D
    Martinelli, G
    Tinazzi, A
    Cavalli, F
    CLINICAL CANCER RESEARCH, 1995, 1 (12) : 1517 - 1524
  • [25] Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer:: A phase I-II study
    Nanni, L
    Palomba, G
    Morelli, F
    Piano, A
    Simeone, A
    D'Alessandro, V
    Sirotovà, Z
    Capuano, G
    Rinaldi, B
    Lelli, G
    JOURNAL OF CHEMOTHERAPY, 2001, 13 (01) : 88 - 92
  • [26] A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer
    Ali, MA
    Kraut, MJ
    Valdivieso, M
    Wozniak, AJ
    Cummings, G
    Kalemkerian, GP
    CANCER INVESTIGATION, 2000, 18 (01) : 1 - 5
  • [27] ETOPOSIDE V ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER - A FONICAP RANDOMIZED STUDY
    ROSSO, R
    ARDIZZONI, A
    SALVATI, F
    GALLOCURCIO, C
    RUBAGOTTI, A
    FUSCO, V
    BRUNETTI, I
    DEPALMA, M
    CRUCSIANI, AR
    PORTALONE, L
    AQUILINI, M
    TONACHELLA, R
    RINALDI, M
    SORESI, E
    SACCANI, F
    CIOFFI, R
    MONACO, M
    SCODITTI, S
    FOLCO, U
    RIMOLDI, R
    LOGROSCINO, C
    PEDICINI, T
    BOTTA, M
    FERRARA, G
    BELLI, M
    SEMINARS IN ONCOLOGY, 1988, 15 (06) : 49 - 51
  • [28] Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
    Nishio, Makoto
    Hida, Toyoaki
    Atagi, Shinji
    Sakai, Hiroshi
    Nakagawa, Kazuhiko
    Takahashi, Toshiaki
    Nogami, Naoyuki
    Saka, Hideo
    Takenoyama, Mitsuhiro
    Maemondo, Makoto
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Hirashima, Tomonori
    Tanaka, Hiroshi
    Fujita, Shiro
    Takeda, Koji
    Goto, Koichi
    Satouchi, Miyako
    Isobe, Hiroshi
    Minato, Koichi
    Sumiyoshi, Naoki
    Tamura, Tomohide
    ESMO OPEN, 2017, 2
  • [29] A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer
    Zarogoulidis, K
    Kontakiotis, T
    Hatziapostolou, P
    Fachantidou, E
    Delis, D
    Goutsikas, J
    Constantinidis, TC
    Athanasiadis, A
    Patakas, D
    LUNG CANCER, 2001, 32 (03) : 281 - 287
  • [30] Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study
    Correale, P.
    Remondo, C.
    Migali, C.
    Licchetta, A.
    Martellucci, I.
    Carbone, S. F.
    Ricci, V.
    Addeo, R.
    Del Prete, S.
    Francini, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 558 - 558
12345